Series B Warrants. (a) To the extent that the Holder of this Note exercises Series B Warrants to receive Common Shares, the Holder may pursuant to the respective terms thereof surrender all or a portion of the Principal Amount of this Note to satisfy the exercise price therefor (a “Surrender of Notes”). In addition, in connection with any In-Kind Make Whole (as defined in the Series B Warrants), the applicable Make Whole Amount shall be added to the outstanding Principal Amount of this Note (a “Principal Accretion”). The Holder shall not be required to physically surrender this Note upon any Surrender of Notes or Principal Accretion. In lieu of physical surrender of this Note, the Holder shall accurately (i) adjust the grid schedule attached hereto as Schedule 1 to reflect any such Surrender of Notes and/or Principal Accretion or (ii) maintain such other accurate records of the outstanding Principal Amount of this Note satisfactory to the Holder, and promptly provide such adjusted grid schedule or other records to the Company. The records of the Holder shall be conclusive, final and binding on the Company absent manifest error.
Series B Warrants. The Series B Warrants shall be exercisable into a number of shares of Common Stock equal to, in the aggregate, 1.0% of the issued and outstanding Common Stock as of the date of issuance of the Warrants.
Series B Warrants. Each Series B Warrant shall, when countersigned by the Warrant Agent, entitle the Registered Holder thereof, subject to the provisions of such Series B Warrant and of this Agreement, to purchase from the Company the number of shares of Common Stock of the Company stated therein, at the price of $8.50 per share, subject to the adjustments provided herein; provided, however, that only whole Series B Warrants may be exercised.
Series B Warrants. Each Series B Warrant may be exercised, in whole or in part, at any time during the period commencing on the Detachment Date and ending at 5:00pm New York City time on May [●], 2018.
Series B Warrants. On the Closing Date, the Company shall issue and deliver the Warrants to the Subscribers as follows: (i) one Warrant to purchase one hundred (100) shares of common Stock shall be issued for each one hundred seventy-five ($175.00) dollars of Purchase Price paid by a Subscriber on the Closing Date. The exercise price to acquire a Warrant Share upon exercise of a Warrant shall be $2.62, subject to adjustment as described in the Warrants. The Warrants shall be exercisable until five (5) years after the Closing Date.
Series B Warrants. At the Effective Time, all Series B Warrants then outstanding shall be assumed by Parent. Each Series B Warrant so assumed by Parent at the Effective Time will continue to have, and be subject to, the same terms and conditions as immediately prior to the Effective Time, except that (i) each Series B Warrant will be exercisable for that number of whole shares of Parent Common Stock equal to the product of the number of shares of Company Series B Preferred Stock that were issuable upon exercise of such Series B Warrant immediately prior to the Effective Time multiplied by the Series B Preferred Exchange Ratio, rounded down to the nearest whole number of shares of Parent Common Stock, and (ii) the per share exercise price for the shares of Parent Common Stock issuable upon exercise of such assumed Series B Warrant will be equal to the quotient determined by dividing the exercise price per share of Company Series B Preferred Stock at which such Series B Warrant was exercisable immediately prior to the Effective Time by the Series B Preferred Exchange Ratio, rounded up to the nearest tenth of a cent.
Series B Warrants. The Consenting Holder shall specify in his, her or its Joinder the number of Series B Warrants owned by the Consenting Holder. In the event that the Consenting Holder does not specify the number of Series B Warrants so owned by the Consenting Holder, the number of Series B Warrants set forth on the books and records of the Company shall be deemed to be the number of Series B Warrants owned by the Consenting Holder for all purposes of this Agreement. In the event of a discrepancy between the number of Series B Warrants specified in the Joinder and the number of Series B Warrants set forth on the books and records of the Company, the Consenting Holder acknowledges that the Consenting Holder’s Joinder will be deemed to be defective and the Company will have the right to require the Consenting Holder to correct the Joinder prior to the Expiration Date or may reject the Joinder in its entirety, in its sole discretion. The Consenting Holder acknowledges that as described in the Consent Solicitation Materials, neither the Company nor any other person shall have any obligation to notify the Consenting Holder of any error or defect in the Consenting Holder’s Joinder.
Series B Warrants. The Company has issued and outstanding warrants to purchase shares of Company Series B Preferred Stock (collectively, the "Series B Warrants"). At the Effective Time, by virtue of the Merger and without any action on the part of the Company, Parent or Acquisition Corp. or the holders of any outstanding Series B Warrants, the right to acquire shares of Company Series B Preferred Stock under the Series B Warrants shall be converted into the right to acquire exactly one-half (1/2) as many shares of Parent Common Stock at an exercise price per share of Parent Common Stock equal to the Blended Offering Price, subject in all respects to the terms and conditions of the Series B Warrants. Except for the change in security underlying the Series B Warrants from Company Series B Preferred Stock to Parent Common Stock, the ratio of exchange and the change in exercise price to the Blended Offering Price, it is the intent of the parties hereto that the Series B Warrants shall continue after the Effective Time, and that the terms and conditions of the Series B Warrants shall otherwise remain unchanged.
Series B Warrants. The documentation representing all of the ----------------- unexercised warrants delivered pursuant to the Series B Purchase Agreement held by such Holder as set forth next to such Holder's name on Schedule II. -----------
Series B Warrants. If the Series B Notes are not repaid in full by September 30, 1998, or upon the earlier occurrence of an Event of Default (as defined in the Revolving Credit Agreement) either (i) described in clause (a) or clause (b) of Section 11 of the Revolving Credit Agreement or (ii) described in clause (c) of Section 11 of the Revolving Credit Agreement and resulting from a default by the Company under Section 9.8, 9.9, 9.10 or 10.1 of the Revolving Credit Agreement, the Exercise Price of the Series B Warrants will be reset to become $.01.
